Akari Therapeutics PLC AKTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/28/24 EDT
1.85UNCH (UNCH)
Volume
13,381
52 week range
1.66 - 5.50
Loading...
  • Open1.89
  • Day High1.90
  • Day Low1.72
  • Prev Close1.86
  • 52 Week High5.50
  • 52 Week High Date08/07/23
  • 52 Week Low1.66
  • 52 Week Low Date03/21/24

Key Stats

  • Market Cap610,592.484
  • Shares Out330,049.99
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-40.22

KEY STATS

  • Open1.89
  • Day High1.90
  • Day Low1.72
  • Prev Close1.86
  • 52 Week High5.50
  • 52 Week High Date08/07/23
  • 52 Week Low1.66
  • 52 Week Low Date03/21/24
  • Market Cap610,592.484
  • Shares Out330,049.99
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-40.22

RATIOS/PROFITABILITY

  • EPS (TTM)-5.68
  • P/E (TTM)-0.33
  • Fwd P/E (NTM)-0.49
  • EBITDA (TTM)-23.084M
  • ROE (TTM)-483.25%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Akari Therapeutics PLC

 

Profile

MORE
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). The...
Raymond Prudo-chlebosz M.D.
Non-Executive Chairman of the Board
Rachelle Jacques
President, Chief Executive Officer, Director
Melissa Bradford-klug
Chief Operating Officer
Wendy Dicicco CPA
Interim Chief Financial Officer
Address
22 BOSTON WHARF ROAD, FL 7
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
CING
Cingulate Inc
1.10UNCHUNCH
ATXI
Avenue Therapeutics Inc
0.1475UNCHUNCH
TENX
Tenax Therapeutics Inc
4.24UNCHUNCH
HOTH
Hoth Therapeutics Inc
1.52UNCHUNCH
OGEN
Oragenics Inc
1.44UNCHUNCH